These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28851925)

  • 21. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.
    Finco O; Frigimelica E; Buricchi F; Petracca R; Galli G; Faenzi E; Meoni E; Bonci A; Agnusdei M; Nardelli F; Bartolini E; Scarselli M; Caproni E; Laera D; Zedda L; Skibinski D; Giovinazzi S; Bastone R; Ianni E; Cevenini R; Grandi G; Grifantini R
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9969-74. PubMed ID: 21628568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
    Badamchi-Zadeh A; McKay PF; Holland MJ; Paes W; Brzozowski A; Lacey C; Follmann F; Tregoning JS; Shattock RJ
    PLoS One; 2015; 10(10):e0141209. PubMed ID: 26501198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection.
    Natividad A; Freeman TC; Jeffries D; Burton MJ; Mabey DC; Bailey RL; Holland MJ
    Infect Immun; 2010 Nov; 78(11):4895-911. PubMed ID: 20823212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection.
    Whittum-Hudson JA; An LL; Saltzman WM; Prendergast RA; MacDonald AB
    Nat Med; 1996 Oct; 2(10):1116-21. PubMed ID: 8837610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring.
    Holland MJ; Bailey RL; Conway DJ; Culley F; Miranpuri G; Byrne GI; Whittle HC; Mabey DC
    Clin Exp Immunol; 1996 Sep; 105(3):429-35. PubMed ID: 8809130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate immunity in ocular Chlamydia trachomatis infection: contribution of IL8 and CSF2 gene variants to risk of trachomatous scarring in Gambians.
    Natividad A; Hull J; Luoni G; Holland M; Rockett K; Joof H; Burton M; Mabey D; Kwiatkowski D; Bailey R
    BMC Med Genet; 2009 Dec; 10():138. PubMed ID: 20015396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration.
    Goodhew EB; Morgan SM; Switzer AJ; Munoz B; Dize L; Gaydos C; Mkocha H; West SK; Wiegand RE; Lammie PJ; Martin DL
    BMC Infect Dis; 2014 Apr; 14():216. PubMed ID: 24755001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlamydia trachomatis infection of the male genital tract: an update.
    Mackern-Oberti JP; Motrich RD; Breser ML; Sánchez LR; Cuffini C; Rivero VE
    J Reprod Immunol; 2013 Nov; 100(1):37-53. PubMed ID: 23870458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serology for trachoma surveillance after cessation of mass drug administration.
    Martin DL; Bid R; Sandi F; Goodhew EB; Massae PA; Lasway A; Philippin H; Makupa W; Molina S; Holland MJ; Mabey DC; Drakeley C; Lammie PJ; Solomon AW
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Chlamydia trachomatis by enzyme immunoassay in patients with trachoma.
    Mabey DC; Robertson JN; Ward ME
    Lancet; 1987 Dec; 2(8574):1491-2. PubMed ID: 2892050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systems serology approach to the investigation of infection-induced antibody responses and protection in trachoma.
    Barton A; Rosenkrands I; Pickering H; Faal N; Harte A; Joof H; Makalo P; Ragonnet M; Olsen AW; Bailey RL; Mabey DCW; Follmann F; Dietrich J; Holland MJ
    Front Immunol; 2023; 14():1178741. PubMed ID: 37287960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
    Campos M; Pal S; O'Brien TP; Taylor HR; Prendergast RA; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host genetic contribution to the cellular immune response to Chlamydia trachomatis: Heritability estimate from a Gambian twin study.
    Bailey RL; Natividad-Sancho A; Fowler A; Peeling RW; Mabey DC; Whittle HC; Jepson AP
    Drugs Today (Barc); 2009 Nov; 45 Suppl B():45-50. PubMed ID: 20011694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma.
    Pickering H; Palmer CD; Houghton J; Makalo P; Joof H; Derrick T; Goncalves A; Mabey DCW; Bailey RL; Burton MJ; Roberts CH; Burr SE; Holland MJ
    Front Cell Infect Microbiol; 2019; 9():297. PubMed ID: 31552195
    [No Abstract]   [Full Text] [Related]  

  • 35. Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
    Harding-Esch EM; Edwards T; Sillah A; Sarr I; Roberts CH; Snell P; Aryee E; Molina S; Holland MJ; Mabey DC; Bailey RL
    PLoS Negl Trop Dis; 2009 Dec; 3(12):e573. PubMed ID: 20027217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.
    Bailey RL; Arullendran P; Whittle HC; Mabey DC
    Lancet; 1993 Aug; 342(8869):453-6. PubMed ID: 8102427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of antigen-specific B cells during experimental ocular Chlamydia trachomatis infection.
    Pal S; Taylor HR; Huneke RB; Prendergast RA; Whittum-Hudson JA
    Infect Immun; 1992 Dec; 60(12):5294-7. PubMed ID: 1452363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of a prototype point-of-care test for ocular Chlamydia trachomatis under field conditions in The Gambia and Senegal.
    Harding-Esch EM; Holland MJ; Schémann JF; Molina S; Sarr I; Andreasen AA; Roberts Ch; Sillah A; Sarr B; Harding EF; Edwards T; Bailey RL; Mabey DC
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1234. PubMed ID: 21829735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-genome sequencing of ocular Chlamydia trachomatis isolates from Gadarif State, Sudan.
    Alkhidir AAI; Holland MJ; Elhag WI; Williams CA; Breuer J; Elemam AE; El Hussain KMK; Ournasseir MEH; Pickering H
    Parasit Vectors; 2019 Nov; 12(1):518. PubMed ID: 31685017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.